Insight Agents GmbH has released two new generic contrast media solutions for injection for the European market.

Magnegita 500 (mu)mol/ml (gadopentetate dimeglumine) will be introduced for MRI in 22 European countries and Iopamigita 300 mg Iod/ml (iopamidol) will be available for x-ray/CT in Germany.